中医药治疗原发性肝癌TACE栓塞综合征的研究进展  

Research Progress on Chinese Medicine in Treating TACE Embolism Syndrome of Primary Liver Cancer

作　　者：彭孟云 朱晓宁 汪静 PENG Mengyun;ZHU Xiaoning;WANG Jing

机构地区：[1]西南医科大学附属中医医院肝胆病科,四川泸州646000

出　　处：《中国中医药现代远程教育》2018年第24期152-154,共3页Chinese Medicine Modern Distance Education of China

基　　金：四川省科技厅项目【No.2017050】

摘　　要：肝动脉介入化疗栓塞术(TACE)是我国中晚期肝癌患者的首选治疗方案,但术后常出现栓塞综合征,增加了患者的痛苦。中医药具有改善TACE栓塞综合征的临床症状、减毒增效的作用。本文将综述中医药治疗原发性肝癌TACE栓塞综合征的文献研究,促进中医药治疗TACE栓塞综合征的推广应用。Transarterial chemoembolization(TACE)is the preferred treatment for patients with advanced primary liver cancer in China,but this treatment easily resulting in embolism syndrome,which increases the pain of patients.Traditional Chinese medicine has the effect of alleviating the clinical symptoms of embolism syndrome,reducing toxicity and increasing efficiency.This article will review the literature researches on the traditional Chinese medicine treatment of embolic syndrome,and promote the development of traditional Chinese medicine in the treatment of embolic syndrome after TACE.

关 键 词：原发性肝癌 介入化疗栓塞术 中医药疗法 栓塞综合征 综述 积聚 

分 类 号：R273[医药卫生—中西医结合]